06/19/2023
The scoping review highlights the crucial need for standardized reporting of health equity in research studies.
During their investigation, the researchers identified 13 additional items that can significantly contribute to the understanding and reporting of health equity. These items cover various aspects, such as defining health equity terms, acknowledging the role of racism and discrimination, considering the composition and training of researchers, incorporating relevant factors in study methods, and facilitating data sharing across equity factors. This comprehensive approach aims to provide a holistic perspective on health equity.
A scoping review establishes need for consensus guidance on reporting health equity in observational studies
To evaluate the support from the available guidance on reporting of health equity in research for our candidate items and to identify additional items for the STROBE (Strengthening Reporting of Observational studies in Epidemiology)-Equity extension.
06/13/2023
Authors often rely on statistical significance alone and may overlook meaningful differences in nonsignificant effect estimates
Beyond Statistical Significance: Nuanced Interpretations of Statistically Nonsignificant Results were Rare in Cochrane Reviews – a Meta-epidemiological Study
To assess the language used by systematic review authors to emphasize that statistically nonsignificant results show meaningful differences. To determine whether the magnitude of these treatment effects was distinct from nonsignificant results that authors interpreted as not different.
06/13/2023
https://www.jclinepi.com/article/S0895-4356%2823%2900089-6/fulltext
The BIGG-REC database makes available all WHO/PAHO evidence-informed recommendations
The BIGG-REC database makes available all WHO/PAHO evidence informed recommendations
To build and maintain a living database of the Pan American Health Organization/World Health Organization (PAHO/WHO) recommendations developed using GRADE.
03/06/2023
The Journal of Clinical Epidemiology is publishing a special issue on Methodological Considerations Related to Equity, Diversion, and Inclusion (EDI) in Clinical Epidemiology. Articles in this special issue will discuss specific methods challenges and solutions related to EDI. All submissions must have a methodological focus. We welcome submissions addressing both quantitative and/or qualitative methods.
Call for papers - Journal of Clinical Epidemiology | ScienceDirect.com by Elsevier
Read the latest articles of Journal of Clinical Epidemiology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
02/13/2023
https://www.jclinepi.com/article/S0895-4356(22)00304-3/fulltext
Assessing the certainty of evidence of test accuracy studies when there are challenges with establishing a reference standard
The commentary published by Dr Reed (ref) highlights challenges that decision-makers, including guideline developers, face when approaching evidence about diagnostic imaging tests. Specifically, the important challenges relate to when the reference standard for a test: 1. is not clearly defined or e...
02/13/2023
https://www.jclinepi.com/article/S0895-4356(22)00344-4/fulltext
Methods for Living Guidelines: Early Guidance based on practical experience. Paper 1: Introduction
To introduce methods for living guidelines based in practical experiences by the Australian Living Evidence Consortium (ALEC), the National Institute of Health and Care Excellence (NICE) and the Infectious Diseases Society of America (IDSA), with methodological support from the United States (US) Gr...
02/13/2023
https://www.jclinepi.com/article/S0895-4356(23)00026-4/fulltext
The life and death of living systematic reviews: a methodological survey
The objectives of this study are to describe the characteristics of Living Systematic Reviews (LSRs) and to understand their life cycles.
02/13/2023
https://www.jclinepi.com/article/S0895-4356(23)00028-8/fulltext
A Delphi consensus checklist helped assess the need to develop rapid guideline recommendations
We aimed to develop a checklist to aid guideline developers in determining which scientific or societal cause (‘triggers’) are relevant when considering to initiate a rapid recommendation procedure.
02/13/2023
https://www.jclinepi.com/article/S0895-4356(23)00032-X/fulltext
CEAs sponsored by the industry were more likely to report ICERs below $50,000/QALY (adjusted odds ratio (OR), 1.91, 95% confidence interval (CI), 1.45-2.51, p
Sponsorship bias in oncology cost effectiveness analysis
Cost effectiveness analysis (CEA) has been increasingly used to inform cancer treatment coverage policy making worldwide. The primary objective of this study was to assess the association between industry sponsorship and CEA results in oncology.